Compare DNUT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNUT | BVS |
|---|---|---|
| Founded | 1937 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.3M | 482.9M |
| IPO Year | 2021 | 2021 |
| Metric | DNUT | BVS |
|---|---|---|
| Price | $3.13 | $8.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $6.22 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 2.3M | 229.2K |
| Earning Date | 02-24-2026 | 03-10-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $1,534,272,000.00 | $563,829,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.19 | $7.11 |
| P/E Ratio | ★ N/A | $52.74 |
| Revenue Growth | N/A | ★ 1.58 |
| 52 Week Low | $2.50 | $5.81 |
| 52 Week High | $9.43 | $11.25 |
| Indicator | DNUT | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 30.33 | 60.08 |
| Support Level | $3.03 | $7.59 |
| Resistance Level | $3.31 | $8.60 |
| Average True Range (ATR) | 0.15 | 0.30 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 13.61 | 64.08 |
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.